Compare TONT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TONT | MNOV |
|---|---|---|
| Founded | 2021 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.5M | 137.8M |
| IPO Year | 2024 | 2004 |
| Metric | TONT | MNOV |
|---|---|---|
| Price | $10.98 | $1.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.25 |
| AVG Volume (30 Days) | ★ 145.6K | 45.6K |
| Earning Date | 11-20-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,360,807.00 |
| Revenue This Year | N/A | $78.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $10.81 | $1.22 |
| 52 Week High | $11.17 | $3.90 |
| Indicator | TONT | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 32.50 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $1.44 |
| Average True Range (ATR) | 0.02 | 0.07 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 15.22 | 6.94 |
Graf Global Corp is a blank check company.
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.